Mirae Asset Global Investments
QTTB icon

Mirae Asset Global Investments’s Q32 Bio QTTB Stock Holding History

Mirae Asset Global Investments’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-472
Closed -$935 – 1757
2025
Q3 		$935 Buy
472
+1
+0.2% +$2 ﹤0.01% 1639
2025
Q2 		$702 Buy
471
+63
+15% +$107 ﹤0.01% 1578
2025
Q1 		$698 Buy
408
+2
+0.5% +$5 ﹤0.01% 1558
2024
Q4 		$1.36K Buy
+406
New +$12.8K ﹤0.01% 1585
2022
Q2 		– Sell
-7,467
Closed -$408K – 2457
2022
Q1 		$408K Sell
7,467
-704
-9% -$43.7K ﹤0.01% 1483
2021
Q4 		$536K Buy
8,171
+1,287
+19% +$125K ﹤0.01% 1431
2021
Q3 		$975K Buy
6,884
+1,295
+23% +$165K ﹤0.01% 1307
2021
Q2 		$732K Buy
5,589
+1,885
+51% +$235K ﹤0.01% 1364
2021
Q1 		$628K Buy
3,704
+1,678
+83% +$353K ﹤0.01% 1248
2020
Q4 		$412K Sell
2,026
-131
-6% -$25.3K ﹤0.01% 1369
2020
Q3 		$416K Buy
2,157
+678
+46% +$152K ﹤0.01% 1235
2020
Q2 		$405K Buy
1,479
+823
+125% +$219K ﹤0.01% 1214
2020
Q1 		$184K Buy
656
+70
+12% +$21.4K ﹤0.01% 1330
2019
Q4 		$219K Buy
+586
New +$168K ﹤0.01% 1423

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments's QTTB Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Q32 Bio (QTTB) in Q4 2025, closing a stake of 472 shares — an estimated $935 sold.

Mirae Asset Global Investments first reported a position in QTTB in Q4 2019 and held it in 14 quarters. The position peaked at $975K in Q3 2021. 52 funds tracked by Wall St. Rank hold QTTB as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining Q32 Bio position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 472 Q32 Bio shares in Q4 2025, an estimated $935.
  • Mirae Asset Global Investments first reported a position in Q32 Bio in Q4 2019 and held it in 14 quarters.
  • Mirae Asset Global Investments's Q32 Bio position peaked at $975K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.